NCT07059728View on ClinicalTrials.gov

High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II

NARecruitingINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Aortic Stenosis Treated With TAVISedation; Aged; Hemodynamics
Interventions
DEVICE

Oxygen therapy during sedation provided via high nasal cannulae (60L/min at 60% FiO2)

Intervention group: Oxygen therapy during sedation provided via high nasal cannulae (60L/min at 60% FiO2)

DEVICE

Oxygen therapy during sedation delivered via nasal cannulae at 5L/min

Control group: Oxygen therapy during sedation delivered via nasal cannulae at 5L/min

Trial Locations (1)

08036

RECRUITING

Hospital Clinic de Barcelona, Barcelona

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER